Ibrutinib, obinutuzumab slowed progression of common leukemia, non-Hodgkin lymphoma.
From the WebMD Archives.
2 Drugs Show Promise Against Blood Cancers
Posted in biotech/medical
Posted in biotech/medical
Ibrutinib, obinutuzumab slowed progression of common leukemia, non-Hodgkin lymphoma.
From the WebMD Archives.